Site Map | Contact Us | Bookmark
 
  Single Disease Educational Content
  Multi-Disease
Educational Content
  Other Resources
  About CLDF
 
 

  

Laparoscopy for liver malignancy oncologically safe: study
01-31-2012
 
     

  

U.S. hepatitis A vaccine rates vary widely
01-25-2012
 
     

  

Four-drug therapy wiped out hepatitis C virus in most cases
01-18-2012
 
     

  

Rituximab helpful against HCV cryoglobulinemic vasculitis
01-13-2012
 
     

 

 View Complete News Library
 

 
       

View content by clicking on a disease specific area listed above

 
 
 
   
     
 
Reporting
on HBV
from DDW
 
 Reporting
on HBV
from EASL
 
 
 
Reporting
on HBV
 
 AASLD
Abstract Review
 
 
 
HBeAG(+)
Patient
 
 Entecavir
and IFN
 
 
 
 HBeAG(-)
Patient
 
   

   View Meeting details!  

   
 

Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection  

Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3  

Viral hepatitis B, active component, U.S. Armed Forces, 2000-2010  

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study  

 View All Articles
 
 
   
       
 

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2011 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource
for US healthcare providers only. Use of this Web site is governed by the CLD Foundation terms of use and privacy statement.